Clinical Trials Directory

Trials / Conditions / Clonal Cytopenia of Undetermined Significance

Clonal Cytopenia of Undetermined Significance

13 registered clinical trials studyying Clonal Cytopenia of Undetermined Significance — 10 currently recruiting.

StatusTrialSponsorPhase
RecruitingEarly Intervention in High Risk CCUS
NCT06802146
Lachelle D. Weeks, MD, PhDEARLY_Phase 1
RecruitingA Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Signifi
NCT06566742
M.D. Anderson Cancer CenterPhase 2
RecruitingEnasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2A Decentralize
NCT06240754
Washington University School of MedicinePhase 2
RecruitingCurcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance,
NCT06063486
University of Southern CaliforniaPhase 2
RecruitingStatins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (M
NCT05483010
Washington University School of MedicinePhase 2
RecruitingClonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
NCT06295965
University of Washington—
RecruitingCanakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Signific
NCT05641831
Uma BoratePhase 2
Active Not RecruitingIvosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1
NCT05030441
Washington University School of MedicinePhase 2
Active Not RecruitingAcquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms
NCT04902833
Massachusetts General Hospital—
CompletedA Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance
NCT05102370
Memorial Sloan Kettering Cancer CenterPhase 1
RecruitingCHIP/CCUS Natural History Protocol
NCT04102423
National Heart, Lung, and Blood Institute (NHLBI)—
RecruitingAscorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomo
NCT03418038
Mayo ClinicPhase 2
RecruitingPre-myeloid Cancer and Bone Marrow Failure Clinic Study
NCT02958462
Mayo ClinicN/A